|
|
Fetal Liver Stem Cells |
| Mid-trimester fetal livers are a rich source of CD34+/++ cells for transplantation |
451 |
| F Golfier,
A Bárcena,
J Cruz,
MR Harrison & MO Muench
|
|
Abstract
Full Article (PDF)
|
|
Progenitor Cell Mobilisation |
| Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma |
463 |
| F Lefrere,
J Makke,
JP Fermand,
JP Marolleau,
L Dal Cortivo,
C Alberti,
V Mouton,
M Benbunan & JM Miclea
|
|
Abstract
Full Article (PDF)
|
|
Peripheral Blood Stem Cells |
| Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells |
467 |
| G Visani,
RM Lemoli,
P Tosi,
G Martinelli,
N Testoni,
P Ricci,
MR Motta,
F Gherlinzoni,
G Leopardi,
R Pastano,
S Rizzi,
PP Piccaluga,
A Isidori & S Tura
|
|
Abstract
Full Article (PDF)
|
|
| Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis |
473 |
| R Kanteti,
KB Miller,
JC McCann,
D Roitman,
J Morelli,
C Hurley,
E Berkman & DP Schenkein
|
|
Abstract
Full Article (PDF)
|
|
CD34+ Cell Kinetics |
| Clearance kinetics of CD34+ cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation |
483 |
| L D’Hondt,
J Wuu,
M André,
C van Lerberghe,
T Guillaume,
A-M Feyens,
Y Humblet,
A Dromelet,
B Chatelain,
J Longueville,
FM Stewart,
V D’Hondt & M Symann
|
|
Abstract
Full Article (PDF)
|
|
Breast Cancer |
| High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy |
491 |
| SI Bearman,
JJ Vredenburgh,
PJ Cagnoni,
EJ Shpall,
Y Nieto,
M Ross,
WP Peters & RB Jones
|
|
Abstract
Full Article (PDF)
|
|
Myeloma |
| Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma |
497 |
| SV Rajkumar,
R Fonseca,
MQ Lacy,
TE Witzig,
JA Lust,
PR Greipp,
TM Therneau,
RA Kyle,
MR Litzow & MA Gertz
|
|
Abstract
Full Article (PDF)
|
|
| Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy |
505 |
| T Aslan,
AB-T Fassas,
R Desikan,
D Siegel,
NC Munshi,
J Mehta,
S Singhal,
B Barlogie & E Anaissie
|
|
Abstract
Full Article (PDF)
|
|
Graft-Versus-Host Disease |
| Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants |
511 |
| JL Liesveld,
RE Duerst,
AP Rapoport,
LS Constine,
CN Abboud,
CH Packman,
LA Wedow,
L Zwetsch,
B McKenna,
T Linder,
WA Silverman,
SB Swift,
JM Rowe & JF DiPersio
|
|
Abstract
Full Article (PDF)
|
|
| Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus |
517 |
| B Mookerjee,
V Altomonte & G Vogelsang
|
|
Abstract
Full Article (PDF)
|
|
Immunotherapy |
| Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation |
521 |
| DE Tsai,
HCF Moore,
CL Hardy,
DL Porter,
EY Loh,
DJ Vaughn,
S Luger,
SJ Schuster & EA Stadtmauer
|
|
Abstract
Full Article (PDF)
|
|
Tumour Cell Contamination |
| RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing’s sarcoma and alveolar rhabdomyosarcoma |
527 |
| B Thomson,
D Hawkins,
J Felgenhauer & JP Radich
|
|
Abstract
Full Article (PDF)
|
|
Immune Recovery |
| Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation |
535 |
| A Abu-Ghosh,
S Goldman,
V Slone,
C van de Ven,
Y Suen,
L Murphy,
L Sender & MS Cairo
|
|
Abstract
Full Article (PDF)
|
|
| The pattern of change in salivary immunoglobulins and antibodies to S. mitis and S. oralis in children undergoing bone marrow transplantation: Use of an indirect method of assessment |
545 |
| VS Lucas,
S Marchant,
SJ Challacombe,
GJ Roberts & D Beighton
|
|
Abstract
Full Article (PDF)
|
|
Infections Post Transplant |
| Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients |
551 |
| M Aljurf,
M Gyger,
A Alrajhi,
E Sahovic,
N Chaudhri,
M Musa,
O Ayoub,
P Seth,
M Aslam, & F Al-Fiar
|
|
Abstract
Full Article (PDF)
|
|
Economic Study |
| Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation |
555 |
| CL Bennett,
TM Waters,
TJ Stinson,
O Almagor,
ZS Pavletic,
SR Tarantolo & MR Bishop
|
|
Abstract
Full Article (PDF)
|
|
Technical Report |
| Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy |
561 |
| SP Dix,
MK Cord,
SJ Howard,
JL Coon,
RJ Belt & RB Geller
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature |
567 |
| TF Leung,
KW Chik,
CK Li,
MMK Shing & PMP Yuen
|
|
Abstract
Full Article (PDF)
|
|
| Inappropriate antidiuretic hormone secretion after high-dose thiotepa |
571 |
| S Sica,
S Cicconi,
F Sorà,
P Chiusolo,
N Piccirillo,
L Laurenti,
E Ortu La Barbera,
G Giordano & G Leone
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Hydrocortisone ointment intravaginally for dysparunia in chronic GVHD |
573 |
| B Lönnqvist & M Brune
|
|
Full Article (PDF)
|
|
